Vardakas K Z, Soteriades E S, Chrysanthopoulou S A, Papagelopoulos P J, Falagas M E
Clin Microbiol Infect. 2005 Oct;11(10):775-7. doi: 10.1111/j.1469-0691.2005.01177.x.
A meta-analysis of randomised controlled trials evaluated the effectiveness and safety of teicoplanin compared to first- or second-generation cephalosporins for perioperative anti-infective prophylaxis in orthopaedic and vascular surgery involving prosthetic material. No differences were found between teicoplanin and cephalosporins with respect to the development of infection at the site of surgery or in remote areas of the body. In addition, there were no significant differences in reported adverse effects or mortality. These findings indicate that both regimens are equally effective in preventing post-operative infections in orthopaedic and vascular surgery involving prosthetic materials.
一项对随机对照试验的荟萃分析评估了替考拉宁与第一代或第二代头孢菌素相比,在涉及假体材料的骨科和血管手术围手术期抗感染预防中的有效性和安全性。在手术部位或身体其他部位的感染发生方面,替考拉宁和头孢菌素之间未发现差异。此外,在报告的不良反应或死亡率方面也没有显著差异。这些发现表明,两种治疗方案在预防涉及假体材料的骨科和血管手术后感染方面同样有效。